Judith Balmaña

32PUBLICATIONS
401CO-AUTHORS
Molecular targetsCancer geneticsGene expression (incl. microarray and other genome-wide approaches)Innate immunityHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Sep 21, 2026
Safety and Efficacy of Ceralasertib plus Olaparib for Advanced/Metastatic Triple-Negative Breast Cancer in Three Molecular Strata: The Phase II VIOLETTE Study.

|Jul 28, 2026
Bridging the gap: integrating hereditary cancer into precision oncology.

|Nov 20, 2025
Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancer.

Daniel R Barnes, Jonathan P Tyrer, Joe Dennis

|Sep 23, 2025
Combination of Olaparib, Durvalumab, and Fulvestrant in Patients with Advanced ER+/HER2- Breast Cancer and Selected Genomic Alterations: Results of the DOLAF Trial.

Séverine Guiu, Judith Balmaña, Pablo Lemercier

|Sep 18, 2025
Exploring communication preferences for disclosing breast cancer risk in women with a family history.

Adrià López-Fernández, Mònica Pardo, Eduard Pérez-Ballestero

|Jun 13, 2025
Niraparib Plus Aromatase Inhibitors for Hormone Receptor-Positive/HER2-Negative Advanced Breast Cancer with a Germline BRCA Mutation.

Laura Lema, José Manuel Pérez-García, Salvador Blanch

Pageof 6

Frequent Collaborators

7 joint publications

Violeta Serra

5 joint publications

Adria Lopez-Fernandez

4 joint publications

Suzette Delaloge

4 joint publications

Josep Tabernero